The Neurological Biomarkers Market in the US is expanding as researchers, pharmaceutical companies, and healthcare providers increasingly utilize biomarkers to support the detection, diagnosis, prognosis, and monitoring of neurological disorders. Market Overview The Neurological Biomarker Market size was estimated to be US$ 5400.90 million in 2021 and US$ XX million in 2023 and is expected to...